While graphene and its derivatives have been suggested as a potential nanomedicine in several biomimetic models, their specific roles in immunological disorders still remain elusive. Graphene quantum dots (GQDs) may be suitable for treating intestinal bowel diseases (IBDs) because of their low toxicity in vivo and ease of clearance. Here, GQDs are intraperitoneally injected to dextran sulfate sodium (DSS)–induced chronic and acute colitis model, and its efficacy has been confirmed. In particular, GQDs effectively prevent tissue degeneration and ameliorate intestinal inflammation by inhibiting TH1/TH17 polarization. Moreover, GQDs switch the polarization of macrophages from classically activated M1 to M2 and enhance intestinal infiltration of regulatory T cells (Tregs). Therefore, GQDs effectively attenuate excessive inflammation by regulating immune cells, indicating that they can be used as promising alternative therapeutic agents for the treatment of autoimmune disorders, including IBDs.
This paper presents an improved design of an AA size electromagnetic energy harvester based on vibration. It utilizes magnetic spring technique to scavenge energy from low frequency external vibration. The optimization of generator is done in two stages. First, ANSYS simulation is used to reduce the nonlinear behavior of flux density and to maximize the output voltage of generator by optimizing size of moving and fixed magnets. Second, the coil width, coil position and load resistance are optimized experimentally to maximize output power. The optimized energy harvester can generate 1.18 mW power at a load resistance of 97 Ω with 9 Hz resonance frequency and 0.5 mm of displacement.
Hematopoietic stem cell transplantation (HSCT) has long served as an unparalleled therapeutic option for numerous hematologic malignancies and genetic disorders. However, the efficacy of HSCT is often limited by suboptimal homing of transplanted stem cells to the bone marrow (BM) niche and insufficient long-term engraftment. Despite the need for effective methods to predict clinical outcomes, a suitable model system remains lacking. In this review, we first examine the biological factors that govern hematopoietic stem cell (HSC) homing and niche interactions, including key chemokine–receptor axes (such as CXCR4–CXCL12) and regulatory molecules that facilitate long-term HSC quiescence and repopulation. We then explore how CRISPR-based gene editing technologies are leveraged to modify HSCs for improved clinical outcomes, while addressing the challenges of DNA damage responses and off-target effects associated with editing. Most importantly, we highlight emerging BM organoid (BMO) systems as next-generation 3-dimensional culture models that recapitulate the human BM microenvironment. BMOs represent a promising platform for preclinical testing of gene-edited HSCs and for investigating human-specific HSC–niche interactions beyond animal models. By integrating gene-edited HSCs with organoid models, researchers can more accurately evaluate HSC homing and engraftment in a precisely mimicked, human-like environment. We also emphasize the potential of combining gene editing with BMO technologies to advance personalized HSCT and pave the way for safer, more effective transplantation procedures. Despite their promise, current BMOs exhibit limitations such as incomplete tissue recapitulation, lack of vascularization, batch variability, and limited long-term stability. Addressing all these challenges will be essential for increasing their physiological relevance and translational potential.